UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Application of antimicrobial stewardship to optimise management of community acquired pneumonia

International journal of clinical practice (Esher), 2011-07, Vol.65 (7), p.775-783

2011

Volltextzugriff (PDF)

Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test

Antimicrobial Agents and Chemotherapy, 1996-08, Vol.40 (8), p.1914-1918

1996

Volltextzugriff (PDF)

association between antibiotic use and resistance: the role of secondary antibiotics

European journal of clinical microbiology & infectious diseases, 2010-09, Vol.29 (9), p.1125-1129

2010

Volltextzugriff (PDF)

Assessment of the Relationship between Antimicrobial Usage and Susceptibility: Differences between the Hospital and Specific Patient-Care Areas

Clinical infectious diseases, 2000-07, Vol.31 (1), p.16-23

2000

Volltextzugriff (PDF)

In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients

Antimicrobial Agents and Chemotherapy, 1997-09, Vol.41 (9), p.2053-2056

1997

Volltextzugriff (PDF)

Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram-Negative Aerobes

Clinical infectious diseases, 1999-05, Vol.28 (5), p.1017-1024

1999

Volltextzugriff (PDF)

Pharmacokinetics of Cefepime in Patients with Thermal Burn Injury

Antimicrobial Agents and Chemotherapy, 1999-12, Vol.43 (12), p.2848-2854

1999

Volltextzugriff (PDF)

The Antimicrobial Armamentarium: Evaluating Current and Future Treatment Options

Pharmacotherapy, 2005-10, Vol.25 (10P2), p.55S-62S

Bosso, John A.

2005

Volltextzugriff (PDF)

A Pilot Study of the Efficacy of Constant-Infusion Ceftazidime in the Treatment of Endobronchial Infections in Adults with Cystic Fibrosis

Pharmacotherapy, 1999-05, Vol.19 (5), p.620-626

1999

Volltextzugriff (PDF)

Pharmacokinetics of cefepime in cystic fibrosis patients

Antimicrobial Agents and Chemotherapy, 1993-07, Vol.37 (7), p.1414-1416

1993

Volltextzugriff (PDF)

Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods

Diagnostic microbiology and infectious disease, 2000-09, Vol.38 (1), p.43-50

2000

Volltextzugriff (PDF)

Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli,Staphylococcus aureus and Bacteroides fragilis

Diagnostic microbiology and infectious disease, 2001, Vol.39 (1), p.39-47

2001

Volltextzugriff (PDF)

Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method

Antimicrobial Agents and Chemotherapy, 1997-11, Vol.41 (11), p.2527-2532

1997

Volltextzugriff (PDF)

The Comparative In Vitro Activity of Ofloxacin and Selected Ophthalmic Antimicrobial Agents Against Ocular Bacterial Isolates

American journal of ophthalmology, 1989-10, Vol.108 (4), p.380-386

1989

Volltextzugriff (PDF)

Comparative activity of cefepime, alone and in combination, against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients

Antimicrobial Agents and Chemotherapy, 1991-04, Vol.35 (4), p.783-784

1991

Volltextzugriff (PDF)

Optimisation of antibiotic therapy in cystic fibrosis patients : pharmacokinetic considerations

Clinical pharmacokinetics, 1993-06, Vol.24 (6), p.496-506

1993

Volltextzugriff (PDF)

In vitro activities of combinations of aztreonam, ciprofloxacin, and ceftazidime against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis

Antimicrobial Agents and Chemotherapy, 1990-03, Vol.34 (3), p.487-488

1990

Volltextzugriff (PDF)

Controlling pneumococcal resistance to penicillin

American journal of health-system pharmacy, 1997-03, Vol.54 (5), p.527-527

Bosso, J A

1997

Volltextzugriff (PDF)

Advances in the pharmacotherapy of cystic fibrosis

Journal of clinical pharmacy and therapeutics, 1992-10, Vol.17 (5), p.263-270

Bosso, John A.

1992

Volltextzugriff (PDF)

Changing susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients with the clinical use of newer antibiotics

Antimicrobial Agents and Chemotherapy, 1989-04, Vol.33 (4), p.526-528

1989

Volltextzugriff (PDF)

Added qualifications for pharmacy specialists: another perspective

The Annals of pharmacotherapy, 1997-12, Vol.31 (12), p.1535-1536

1997

Volltextzugriff (PDF)

Use of ciprofloxacin in cystic fibrosis patients

American Journal of Medicine [AM. J. MED.]. Vol. 87, no. 5A. 1989, 1989-11, Vol.87 (5), p.S123-S127

1989

Volltextzugriff (PDF)

The role of dornase alfa in the treatment of cystic fibrosis

The Annals of pharmacotherapy, 1996-06, Vol.30 (6), p.656-661

1996

Volltextzugriff (PDF)

Bacterial resistance to antibiotics: mechanisms and prevalence in hospitals and nursing homes

DICP (Cincinnati, Ohio), 1989-07, Vol.23 (7-8), p.556-561

Bosso, J A

1989

Volltextzugriff (PDF)

Toxicity of colistin in cystic fibrosis patients

DICP (Cincinnati, Ohio), 1991-11, Vol.25 (11), p.1168-1170

1991

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(304)
Mit Volltextzugriff
(261)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(159)
Humans
(104)
Pharmacology & Pharmacy
(82)
Biological And Medical Sciences
(71)
Medical Sciences
(63)
Pharmacology. Drug Treatments
(47)
Female
(41)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(40)
Male
(40)
Antibacterial Agents
(37)
Microbiology
(31)
Adult
(29)
Animals
(26)
Microbial Sensitivity Tests
(22)
Infectious Diseases
(21)
Social Sciences
(19)
Physical Sciences
(18)
Adolescent
(16)
Chemistry
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Application of antimicrobial stewardship to optimise management of community acquired pneumonia

Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test

association between antibiotic use and resistance: the role of secondary antibiotics

Assessment of the Relationship between Antimicrobial Usage and Susceptibility: Differences between the Hospital and Specific Patient-Care Areas

In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients

Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram-Negative Aerobes

Pharmacokinetics of Cefepime in Patients with Thermal Burn Injury

The Antimicrobial Armamentarium: Evaluating Current and Future Treatment Options

A Pilot Study of the Efficacy of Constant-Infusion Ceftazidime in the Treatment of Endobronchial Infections in Adults with Cystic Fibrosis

Pharmacokinetics of cefepime in cystic fibrosis patients

Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods

Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli,Staphylococcus aureus and Bacteroides fragilis

Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method

The Comparative In Vitro Activity of Ofloxacin and Selected Ophthalmic Antimicrobial Agents Against Ocular Bacterial Isolates

Comparative activity of cefepime, alone and in combination, against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients

Optimisation of antibiotic therapy in cystic fibrosis patients : pharmacokinetic considerations

In vitro activities of combinations of aztreonam, ciprofloxacin, and ceftazidime against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis

Controlling pneumococcal resistance to penicillin

Advances in the pharmacotherapy of cystic fibrosis

Changing susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients with the clinical use of newer antibiotics

Added qualifications for pharmacy specialists: another perspective

Use of ciprofloxacin in cystic fibrosis patients

The role of dornase alfa in the treatment of cystic fibrosis

Bacterial resistance to antibiotics: mechanisms and prevalence in hospitals and nursing homes

Toxicity of colistin in cystic fibrosis patients

Suchergebnisse filtern